Pharma Business - May 5, 2015
Novo Opening New Facility
Novo Nordisk broke ground May 4 on a new 7,500 m2 manufacturing facility in Kalundborg, Denmark. The company is investing 1.5 billion Danish kroner in the facility, which will produce active pharmaceutical ingredients for NovoSeven®and future products for treating hemophilia. The investment is estimated to create 100 new production and engineering jobs in Kalundborg, where […]
Agreement - February 11, 2015
Novo Joins Research Team
Novo Nordisk and Merck are the newest members of the GPCR Consortium, a global nonprofit researching a little-understood protein. The group, which also includes Amgen, Sanofi and Ono, is concentrating on proteins called G-protein coupled receptors (GPCRs), which play a role in a wide variety of processes in the body. Working with universities in China and […]